AMANDA NELSON: Open Payments
NPI 1932509072 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 17 payments from 9 companies in 2025. Trend: 2023 $6,927 · 2024 $296 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| Bausch Health US, LLC | 4 | $70 |
| Neurocrine BioSciences, Inc. | 2 | $61 |
| Corium, LLC | 3 | $52 |
| ABBVIE INC. | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| Braeburn Inc. | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Biogen, Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
Products named: APLENZIN, INGREZZA, Azstarys, VRAYLAR, REXULTI, BRIXADI, AUSTEDO XR, ZURZUVAE.
Industry payments across CA — which companies pay providers there.
